Clinical Trial
[Controlled study of treatment of steroids and chlorambucil, in alternate months, for membranous nephropathy and focal glomerulosclerosis. Preliminary evaluation of the results]
[Article in
Italian]
- PMID: 7019771
Item in Clipboard
Clinical Trial
[Controlled study of treatment of steroids and chlorambucil, in alternate months, for membranous nephropathy and focal glomerulosclerosis. Preliminary evaluation of the results]
[Article in
Italian]
Minerva Nefrol.
1980 Oct-Dec.
No abstract available
Similar articles
-
Controlled trial of monthly alternated courses of steroid and chlorambucil for idiopathic membranous nephropathy.Proc Eur Dial Transplant Assoc. 1983;19:717-23. Proc Eur Dial Transplant Assoc. 1983. PMID: 6348763 Clinical Trial.
-
Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.N Engl J Med. 1984 Apr 12;310(15):946-50. doi: 10.1056/NEJM198404123101503. N Engl J Med. 1984. PMID: 6366560 Clinical Trial.
-
Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group.N Engl J Med. 1992 Aug 27;327(9):599-603. doi: 10.1056/NEJM199208273270904. N Engl J Med. 1992. PMID: 1640953 Clinical Trial.
-
[Idiopathic membranous nephropathy].Minerva Nefrol. 1983 Jan-Mar;30(1):7-10. Minerva Nefrol. 1983. PMID: 6341889 Review. Italian. No abstract available.
-
[Immunosuppressive therapy of glomerulonephritis--controlled studies].Ther Umsch. 1993 Feb;50(2):119-29. Ther Umsch. 1993. PMID: 8456416 Review. German.
Cited by
-
Efficacy and safety of nine immunosuppressive agents for primary focal segmental glomerulosclerosis in adults: a pairwise and network meta-analysis.Ren Fail. 2024 Dec;46(2):2438861. doi: 10.1080/0886022X.2024.2438861. Epub 2024 Dec 11. Ren Fail. 2024. PMID: 39663153 Free PMC article.
-
Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.Cochrane Database Syst Rev. 2014 Oct 16;2014(10):CD004293. doi: 10.1002/14651858.CD004293.pub3. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2021 Nov 15;11:CD004293. doi: 10.1002/14651858.CD004293.pub4. PMID: 25318831 Free PMC article. Updated.
-
Immunosuppressive treatment for focal segmental glomerulosclerosis in adults.Cochrane Database Syst Rev. 2008 Jul 16;2008(3):CD003233. doi: 10.1002/14651858.CD003233.pub2. Cochrane Database Syst Rev. 2008. Update in: Cochrane Database Syst Rev. 2022 Feb 28;2:CD003233. doi: 10.1002/14651858.CD003233.pub3. PMID: 18646090 Free PMC article. Updated.
-
Calcineurin Inhibitors in the Treatment of Primary Focal Segmental Glomerulosclerosis: A Systematic Review and Meta-analysis of the Literature.Can J Kidney Health Dis. 2017 Feb 22;4:2054358117692559. doi: 10.1177/2054358117692559. eCollection 2017. Can J Kidney Health Dis. 2017. PMID: 28321320 Free PMC article. Review.
-
Interventions for focal segmental glomerulosclerosis in adults.Cochrane Database Syst Rev. 2022 Feb 28;2(2):CD003233. doi: 10.1002/14651858.CD003233.pub3. Cochrane Database Syst Rev. 2022. PMID: 35224732 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical